1. |
Chen J, Li X, Ge C, et al. The multifaceted role of ferroptosis in liver disease. Cell Death Differ, 2022, 29(3): 467-480.
|
2. |
Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell, 2012, 149(5): 1060-1072.
|
3. |
张维志, 刘连新. 铁死亡机制在肝细胞癌及其耐药中的研究现状与前景. 中国普外基础与临床杂志, 2022, 29(5): 694-700.
|
4. |
Doll S, Conrad M. Iron and ferroptosis: A still ill-defined liaison. IUBMB Life, 2017, 69(6): 423-434.
|
5. |
Pan Q, Luo Y, Xia Q, et al. Ferroptosis and liver fibrosis. Int J Med Sci, 2021, 18(15): 3361-3366.
|
6. |
Yamada N, Karasawa T, Wakiya T, et al. Iron overload as a risk factor for hepatic ischemia-reperfusion injury in liver transplantation: Potential role of ferroptosis. Am J Transplant, 2020, 20(6): 1606-1618.
|
7. |
Mazhar M, Din AU, Ali H, et al. Implication of ferroptosis in aging. Cell Death Discov, 2021, 7(1): 149.
|
8. |
Zhou RP, Chen Y, Wei X, et al. Novel insights into ferroptosis: Implications for age-related diseases. Theranostics, 2020, 10(26): 11976-11997.
|
9. |
Chen X, Li J, Kang R, et al. Ferroptosis: machinery and regulation. Autophagy, 2021, 17(9): 2054-2081.
|
10. |
Li J, Cao F, Yin HL, et al. Ferroptosis: past, present and future. Cell Death Dis, 2020, 11(2): 88.
|
11. |
Capelletti MM, Manceau H, Puy H, et al. Ferroptosis in liver diseases: an overview. Int J Mol Sci, 2020, 21(14): 4908.
|
12. |
Bochkov VN, Oskolkova OV, Birukov KG, et al. Generation and biological activities of oxidized phospholipids. Antioxid Redox Signal, 2010, 12(8): 1009-1059.
|
13. |
Ursini F, Maiorino M. Lipid peroxidation and ferroptosis: The role of GSH and GPx4. Free Radic Biol Med, 2020, 152: 175-185.
|
14. |
Yu Y, Jiang L, Wang H, et al. Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis. Blood, 2020, 136(6): 726-739.
|
15. |
Daher R, Manceau H, Karim Z. Iron metabolism and the role of the iron-regulating hormone hepcidin in health and disease. Presse Med, 2017, 46(12 Pt 2): e272-e278. doi: 10.1016/j.lpm.2017.10.006.
|
16. |
He YJ, Liu XY, Xing L, et al. Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator. Biomaterials, 2020, 241: 119911.
|
17. |
Magtanong L, Ko PJ, To M, et al. Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state. Cell Chem Biol, 2019, 26(3): 420-432.
|
18. |
Zeng F, Lan Y, Wang N, et al. Ferroptosis: A new therapeutic target for bladder cancer. Front Pharmacol, 2022, 13: 1043283.
|
19. |
Conrad M, Pratt DA. The chemical basis of ferroptosis. Nat Chem Biol, 2019, 15(12): 1137-1147.
|
20. |
周伟, 吴河水. 铁死亡机制在胰腺癌中的研究现状及未来展望. 中国普外基础与临床杂志, 2023, 30(3): 364-368.
|
21. |
Zhu T, Shi L, Yu C, et al. Ferroptosis promotes photodynamic therapy: supramolecular photosensitizer-inducer nanodrug for enhanced cancer treatment. Theranostics, 2019, 9(11): 3293-3307.
|
22. |
Gracia-Sancho J, Casillas-Ramírez A, Peralta C. Molecular pathways in protecting the liver from ischaemia/reperfusion injury: a 2015 update. Clin Sci (Lond), 2015, 129(4): 345-362.
|
23. |
Friedmann Angeli JP, Schneider M, Proneth B, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol, 2014, 16(12): 1180-1191.
|
24. |
Fang X, Wang H, Han D, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci U S A, 2019, 116(7): 2672-2680.
|
25. |
Li Y, Feng D, Wang Z, et al. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion. Cell Death Differ, 2019, 26(11): 2284-2299.
|
26. |
Wu Y, Jiao H, Yue Y, et al. Ubiquitin ligase E3 HUWE1/MULE targets transferrin receptor for degradation and suppresses ferroptosis in acute liver injury. Cell Death Differ, 2022, 29(9): 1705-1718.
|
27. |
Levy MM, Dellinger RP, Townsend SR, et al. The Surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med, 2010, 38(2): 367-374.
|
28. |
Kallinen O, Maisniemi K, Böhling T, et al. Multiple organ failure as a cause of death in patients with severe burns. J Burn Care Res, 2012, 33(2): 206-211.
|
29. |
Kramer L, Jordan B, Druml W, et al. Incidence and prognosis of early hepatic dysfunction in critically ill patients—a prospective multicenter study. Crit Care Med, 2007, 35(4): 1099-1104.
|
30. |
Hall MJ, Levant S, DeFrances CJ. Trends in inpatient hospital deaths: national hospital discharge survey, 2000–2010. NCHS Data Brief, 2013, 118: 1-8.
|
31. |
Mancias JD, Wang X, Gygi SP, et al. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature, 2014, 509(7498): 105-109.
|
32. |
Li Q, Han X, Lan X, et al. Inhibition of neuronal ferroptosis protects hemorrhagic brain. JCI Insight, 2017, 2(7): e90777.
|
33. |
Li N, Wang W, Zhou H, et al. Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury. Free Radic Biol Med, 2020, 160: 303-318.
|
34. |
Wang C, Yuan W, Hu A, et al. Dexmedetomidine alleviated sepsis-induced myocardial ferroptosis and septic heart injury. Mol Med Rep, 2020, 22(1): 175-184.
|
35. |
Wang J, Zhu Q, Li R, et al. YAP1 protects against septic liver injury via ferroptosis resistance. Cell Biosci, 2022, 12(1): 163.
|
36. |
Andrade RJ, Chalasani N, Björnsson ES, et al. Drug-induced liver injury. Nat Rev Dis Primers, 2019, 5(1): 58.
|
37. |
Kullak-Ublick GA, Andrade RJ, Merz M, et al. Drug-induced liver injury: recent advances in diagnosis and risk assessment. Gut, 2017, 66(6): 1154-1164.
|
38. |
Ettel M, Gonzalez GA, Gera S, et al. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center. Hum Pathol, 2017, 68: 92-98.
|
39. |
Jaeschke H, Xie Y, McGill MR. Acetaminophen-induced liver injury: from animal models to humans. J Clin Transl Hepatol, 2014, 2(3): 153-161.
|
40. |
Ding CH, Zhu H. Isatidis folium alleviates acetaminophen-induced liver injury in mice by enhancing the endogenous antioxidant system. Environ Toxicol, 2020, 35(11): 1251-1259.
|
41. |
Yamada N, Karasawa T, Kimura H, et al. Ferroptosis driven by radical oxidation of n-6 polyunsaturated fatty acids mediates acetaminophen-induced acute liver failure. Cell Death Dis, 2020, 11(2): 144.
|
42. |
Yan B, Ai Y, Sun Q, et al. Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1. Mol Cell, 2021, 81(2): 355-369.
|
43. |
Nagra N, Kozarek RA, Burman BE. Therapeutic advances in viral hepatitis A-E. Adv Ther, 2022, 39(4): 1524-1552.
|
44. |
Kan X, Yin Y, Song C, et al. Newcastle-disease-virus-induced ferroptosis through nutrient deprivation and ferritinophagy in tumor cells. iScience, 2021, 24(8): 102837.
|
45. |
Girelli D, Pasino M, Goodnough JB, et al. Reduced serum hepcidin levels in patients with chronic hepatitis C. J Hepatol, 2009, 51(5): 845-852.
|
46. |
Fujita N, Sugimoto R, Takeo M, et al. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C. Mol Med, 2007, 13(1-2): 97-104.
|
47. |
Armitage AE, Stacey AR, Giannoulatou E, et al. Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections. Proc Natl Acad Sci U S A, 2014, 111(33): 12187-12192.
|
48. |
Fujita N, Takei Y. Iron, hepatitis C virus, and hepatocellular carcinoma: iron reduction preaches the gospel for chronic hepatitis C. J Gastroenterol, 2007, 42(11): 923-926.
|
49. |
Martin DN, Uprichard SL. Identification of transferrin receptor 1 as a hepatitis C virus entry factor. Proc Natl Acad Sci U S A, 2013, 110(26): 10777-10782.
|
50. |
Gao M, Yi J, Zhu J, et al. Role of Mitochondria in ferroptosis. Mol Cell, 2019, 73(2): 354-363.
|
51. |
Zou DM, Sun WL. Relationship between Hepatitis C virus infection and iron overload. Chin Med J (Engl), 2017, 130(7): 866-871.
|
52. |
Li W, Urban S. Entry of hepatitis B and hepatitis D virus into hepatocytes: Basic insights and clinical implications. J Hepatol, 2016, 64(1 Suppl): S32-S40. doi: 10.1016/j.jhep.2016.02.011.
|
53. |
Czaja AJ. Diagnosis and Management of autoimmune hepatitis: current status and future directions. Gut Liver, 2016, 10(2): 177-203.
|
54. |
Deng G, Li Y, Ma S, et al. Caveolin-1 dictates ferroptosis in the execution of acute immune-mediated hepatic damage by attenuating nitrogen stress. Free Radic Biol Med, 2020, 148: 151-161.
|
55. |
Zeng T, Deng G, Zhong W, et al. Indoleamine 2, 3-dioxygenase 1enhanceshepatocytes ferroptosis in acute immune hepatitis associated with excess nitrative stress. Free Radic Biol Med, 2020, 152: 668-679.
|
56. |
Shojaie L, Iorga A, Dara L. Cell death in liver diseases: a review. Int J Mol Sci, 2020, 21(24): 9682.
|
57. |
Bekric D, Ocker M, Mayr C, et al. Ferroptosis in hepatocellular carcinoma: mechanisms, drug targets and approaches to clinical translation. Cancers (Basel), 2022, 14(7): 1826.
|
58. |
Angeli JPF, Shah R, Pratt DA, et al. Ferroptosis inhibition: mechanisms and opportunities. Trends Pharmacol Sci, 2017, 38(5): 489-498.
|